| Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint … DF Hanley, RE Thompson, M Rosenblum, G Yenokyan, K Lane, N McBee, ... The Lancet 393 (10175), 1021-1032, 2019 | 556 | 2019 |
| Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial DF Hanley, K Lane, N McBee, W Ziai, S Tuhrim, KR Lees, J Dawson, ... The Lancet 389 (10069), 603-611, 2017 | 382 | 2017 |
| Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial NS Padian, A van der Straten, G Ramjee, T Chipato, G de Bruyn, ... The Lancet 370 (9583), 251-261, 2007 | 374 | 2007 |
| Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trial DF Hanley, RE Thompson, J Muschelli, M Rosenblum, N McBee, K Lane, ... The Lancet Neurology 15 (12), 1228-1237, 2016 | 319 | 2016 |
| The risk of virologic failure decreases with duration of HIV suppression, at greater than 50% adherence to antiretroviral therapy M Rosenblum, SG Deeks, M van der Laan, DR Bangsberg PloS one 4 (9), e7196, 2009 | 145 | 2009 |
| Accuracy of the ABC/2 score for intracerebral hemorrhage: systematic review and analysis of MISTIE, CLEAR-IVH, and CLEAR III AJS Webb, NL Ullman, TC Morgan, J Muschelli, J Kornbluth, IA Awad, ... Stroke 46 (9), 2470-2476, 2015 | 143 | 2015 |
| A randomized controlled trial of mental health interventions for survivors of systematic violence in Kurdistan, Northern Iraq P Bolton, JK Bass, GAS Zangana, T Kamal, SMI Murray, D Kaysen, ... BMC psychiatry 14, 1-15, 2014 | 121 | 2014 |
| Leveraging prognostic baseline variables to gain precision in randomized trials E Colantuoni, M Rosenblum Statistics in medicine 34 (18), 2602-2617, 2015 | 84 | 2015 |
| Targeted maximum likelihood estimation of the parameter of a marginal structural model M Rosenblum, MJ Van Der Laan The international journal of biostatistics 6 (2), 2010 | 80 | 2010 |
| Using regression models to analyze randomized trials: Asymptotically valid hypothesis tests despite incorrectly specified models M Rosenblum, MJ Van Der Laan Biometrics 65 (3), 937-945, 2009 | 76 | 2009 |
| Simple, efficient estimators of treatment effects in randomized trials using generalized linear models to leverage baseline variables M Rosenblum, MJ Van Der Laan The international journal of biostatistics 6 (1), 2010 | 69 | 2010 |
| Optimizing randomized trial designs to distinguish which subpopulations benefit from treatment M Rosenblum, MJ van der Laan Biometrika 98 (4), 845-860, 2011 | 66 | 2011 |
| Improving precision and power in randomized trials for COVID‐19 treatments using covariate adjustment, for binary, ordinal, and time‐to‐event outcomes D Benkeser, I Díaz, A Luedtke, J Segal, D Scharfstein, M Rosenblum Biometrics 77 (4), 1467-1481, 2021 | 51 | 2021 |
| Analysis of covariance in randomized trials: More precision and valid confidence intervals, without model assumptions B Wang, EL Ogburn, M Rosenblum Biometrics 75 (4), 1391-1400, 2019 | 49 | 2019 |
| Improved precision in the analysis of randomized trials with survival outcomes, without assuming proportional hazards I Díaz, E Colantuoni, DF Hanley, M Rosenblum Lifetime data analysis 25, 439-468, 2019 | 44 | 2019 |
| Estimating population treatment effects from a survey subsample KE Rudolph, I Díaz, M Rosenblum, EA Stuart American journal of epidemiology 180 (7), 737-748, 2014 | 36 | 2014 |
| Multifocal cryoballoon ablation for eradication of Barrett's esophagus-related neoplasia: A prospective multicenter clinical trial MI Canto, AJ Trindade, J Abrams, M Rosenblum, J Dumot, A Chak, P Iyer, ... Official journal of the American College of Gastroenterology| ACG 115 (11 …, 2020 | 34 | 2020 |
| Improving precision by adjusting for prognostic baseline variables in randomized trials with binary outcomes, without regression model assumptions JA Steingrimsson, DF Hanley, M Rosenblum Contemporary clinical trials 54, 18-24, 2017 | 34 | 2017 |
| Basic and translational research in intracerebral hemorrhage M Selim, D Hanley, J Broderick, JN Goldstein, BA Gregson, G Falcione, ... Stroke 49 (5), 1308-1314, 2018 | 32 | 2018 |
| Unmet needs and challenges in clinical research of intracerebral hemorrhage MCT Predispose Stroke 49, 00-00, 2018 | 32 | 2018 |
Mark van der LaanJiann-Ping Hsu/Karl E. Peace Professor of Biostatistics & Statistics, University of California BerkeleyVerified email at berkeley.edu
